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ABSTRACT
Revised Model for Antibiotic resistance in Hospital
by
Ruhang Pei
In this thesis we modify an existing model for the spread of resistant bacteria in a
hospital. The existing model does not account for some of the trends seen in the
data found in literature. The new model takes some of these trends into account.
For the new model, we examine issues relating to identifiability, sensitivity analysis,
parameter estimation, uncertainty analysis, and equilibrium stability.
2
Copyright by Ruhang Pei 2015
3
ACKNOWLEDGMENTS
I would like to acknowledge my thesis adviser, Dr. Michele Joyner. She has given
me so much help. I am really appreciate her patience, kindness, and guidance. I
would also like to acknowledge Dr. Anant Godbole. He is the person who created
the bridge-program which give me the opportunity to study in the USA. Studying at
ETSU will be my most beautiful time in my life.
4
TABLE OF CONTENTS
ABSTRACT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2
ACKNOWLEDGMENTS . . . . . . . . . . . . . . . . . . . . . . . . . . . 4
LIST OF TABLES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6
LIST OF FIGURES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7
1 INTRODUCTION . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8
2 MODEL DEVELOPMENT . . . . . . . . . . . . . . . . . . . . . . . 10
3 IDENTIFIABILITY AND SENSITIVITY ANALYSIS . . . . . . . . . 16
4 PARAMETER ESTIMATION . . . . . . . . . . . . . . . . . . . . . . 21
5 UNCERTAINTY ANALYSIS . . . . . . . . . . . . . . . . . . . . . . 26
6 EQUILIBRIUM AND STABILITY ANALYSIS . . . . . . . . . . . . 30
7 CONCLUTIONS AND FUTURE WORK . . . . . . . . . . . . . . . 33
BIBLIOGRAPHY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34
VITA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 38
5
LIST OF TABLES
1 Definitions of Parameters . . . . . . . . . . . . . . . . . . . . . . . . . 14
2 New parameter values for identifiability . . . . . . . . . . . . . . . . . 19
3 Estimated Parameter Values and Calculated Error . . . . . . . . . . . 24
4 Confidence Interval for Parameter Estimates . . . . . . . . . . . . . . 28
6
LIST OF FIGURES
1 Simulation of Original Model developed by Joyner et al. [1] . . . . . . 10
2 Schematic for the revised model after making the revisions discussed
in Section 2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13
3 Simulation for the new model given by Eq. (1) . . . . . . . . . . . . . 15
4 Sensitivity analysis for the model given by Eq (1) . . . . . . . . . . . 18
5 Schematic for the reparameterized model . . . . . . . . . . . . . . . . 20
6 Solution to Eq (5) with both exact parameters and estimated param-
eters given in Table 3 together with simulated data . . . . . . . . . . 25
7 Variation in the solution M(t, qˆm) in Eq. (5) given the variability in
parameter values seen in Table 4 . . . . . . . . . . . . . . . . . . . . 29
7
1 INTRODUCTION
Antibiotic resistance occurs when an antibiotic has lost its effectiveness against
the bacteria it is trying to kill. Normally, the bacteria is killed by an antibiotic, but
in some situations, like the overuse of antibiotics, development of bacterial resistance
of an antibiotic can occur. Drugs can lose their ability to kill bacteria and thus
cure patients. It happens frequently in various hospital settings. [26] Patients will
not get better immediately because of antibiotic resistance. This resistance, in turn,
makes it harder for medical staff to treat patients effectively for their illnesses. The
development and occurrence of antibiotic resistance cannot be eliminated completely,
but there may be ways to reduce its occurrence. Joyner et al. [1]. introduced a model
to simulate the spread of antibiotic resistant bacteria to two drugs in a hospital setting.
Patients were categorized as colonized with either resistant bacteria or uncolonized.
The colonized patients were separated into four groups. It was assumed that four
types of colonized patients could influence each other, and colonized and uncolonized
patients could also affect each other. The simulation of the model in Joyner et
al. [1] shows that the proportion of patients colonized with dual antibiotic resistant
bacteria are higher than other proportions of patients. It was explained that this
was possibly due to the assumption that there was no treatment for those patients.
This is unrealistic.The majority of patients are likely to be colonized with bacteria
sensitive to antibiotics [2]. In this thesis, we focused on revising the model by Joyner
et al. [1] to try to more accurately represent the trend in a hospital.
We illustrate how we changed the previous model to get the new model in Section
2. In Section 3 we analyze the identifiability of the parameters in the new model and
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the sensitivity of the variables to the parameter values. In Section 4, we focused on
parameter estimation. In section 5, we address uncertainty in the model. In Section
6, we focus on the existence and stability of a resistant-free equilibrium. We end the
thesis with some final conclusions and remarks about future work.
9
2 MODEL DEVELOPMENT
In this section, we discuss the specific modifications to an existing model for the
spread of antibiotic resistance in a hospital setting. The original model by Joyner
et al. [1] is a compartmental model in which patients are classified in one of five
categories based on their bacterial colonization. It is assumed there are only two
drugs and patients can be resistant to one, two or none of the antibiotics. Resistance
may then be transmitted to patients who are uncolonized or colonized with a type
of resistance which spreads faster. Patients can become uncolonized either through
treatment or through their immune system fighting off the bacteria. The simulation
of the original model is shown in Figure 1.
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Figure 1: Simulation of Original Model developed by Joyner et al. [1]
Figure 1 shows that after approximately 20 days of treatment, the proportion of
patients in the hospital colonized with dual resistance is approximately 72%. The
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proportion of patients uncolonized and colonized with sensitive bacteria are approxi-
mately 16% and 10%, respectively. The proportion of patients with single resistance
is only around 2%. The simulation is not what is expected based on observed hospital
data [2]. The proportion of the hospital colonized with dual resistance should be
lower than the proportion of the hospital colonized with single resistance as shown in
the data by Takesque et al. [2]. In our model, we focus on new assumptions which
might more accurately show what occurs in a hospital setting.
The first change in the model is a change in the model variables. We let S be the
proportion of patients with bacteria sensitive to all drugs in the hospital. We let R be
the proportion of patients colonized with bacteria resistant to only a single antibiotic.
We let M be the proportion of patients colonized with bacteria resistant to multiple
antibiotics, and X represents the proportion of patients who are uncolonized. We
assume a constant population in the hospital, so S +R+M +X = 1. Analyzing the
simulation from the original model, we made three major changes. First, we assumed
there is treatment available for patients colonized with multiple-resistant bacteria [3].
The previous model assumed there was no antibiotic available to treat dual resistance
(thus the proportion of people colonized with dual resistance was much higher than
what is typically seen in the hospital). Therefore, we instead chose to assume a
variable which included all patients colonized with bacteria resistant to more than
one drug, but instead of assuming there are no antibiotics to treat them, we instead
assume they can be treated at a rate τM , a slower rate than treatment of patients
colonized with either bacteria resistant to a single antibiotic or colonized with sensitive
bacteria. Second, we assume that resistance can develop during treatment [9]. We
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assume resistance can develop during treatment at a rate eτ , reducing the effective
treatment rate from τ to (1− eτ )τ where 0 < eτ < 1. The third major change is that
we assume there can be transfer of resistant mechanisms from bacteria to bacteria
[4, 5]. When two bacteria are close to each other, conjugation can occur in which one
bacteria can transfer the mechanism for antibiotic resistance to the other bacteria
causing both bacteria to be resistant to the antibiotic. We assume that conjugation
can only occur through either direct or indirect contact. A plasmid transfer rate βpT
is assumed in the new model. For example, βpTRM is the development of multiple
resistant bacteria due to the transfer of a second resistant mechanism to a single
resistant bacteria. The schematic for the new model is given in Figure 2 with the
parameters in Table 1. The model is given by the set of differential equations
dS
dt
= λmS − SµS + βS[X − pTR]− (τ + γ)S, (1)
dR
dt
= λmR −RµR + βR[(1− cR)X + pT (S −R−M)]− (τR + γ)R
+eττS,
dM
dt
= λmM −MµM + βM [(1− cM)X + pTR] + βpTR2 + eττRR
−M [τm(1− eτ ) + γ].
Since we assume a constant hospital population, the differential equation for X is
defined by the relationship
dX
dt
= 1− dS
dt
− dR
dt
− dM
dt
.
12
Figure 2: Schematic for the revised model after making the revisions discussed in
Section 2
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Table 1: Definitions of Parameters
Parameters Description value ref.
β colonization rate 1/day [21, 24]
pT probability of plasmid transfer
upon contact 10−6/day [4, 5]
cR fitness cost of bacteria resistant
to single drug 0.05/day [21]
cM fitness cost of bacteria resistant
to multiple drugs 0.15/day [21]
τ per capita treatment rate of
sensitive bacteria (∼ 31 hours) 0.78/day [9]
τR per capita treatment rate of
resistance to a single drug
(∼ 1/2 day longer than sensitive) 0.56/day [12]
τM per capita treatment rate of
resistance to multiple drugs.
(∼ 2x as long as sensitive) 0.39/day [3]
eτ rate of resistance developing
during treatment 10−7/day [20, 22, 23]
γ per capita clearance rate of
bacteria due to immune response 0.03/day [21, 24, 25]
µS patients discharge rate for S 0.7/day [11]
µR patients discharge rate for R 0.05/day estimated
µM patients discharge rate for M 0.005/day estimated
µX patients discharge rate for X 0.245/day [10]
The simulation of the new model is shown in Figure 3. By comparing the difference
between the new simulation (Figure 3) and the previous simulations (Figure 1), the
proportion of patients with bacteria of multiple antibiotic resistances is lower than
the proportion of patients with bacteria of single antibiotic resistance as hoped. The
simulation also shows that the majority of patients are either uncolonized or colonized
with bacteria sensitive to antibiotics which is more in line with what is expected.
However, the proportion of uncolonized is expected to be lower than the proportion
14
of patients with colonized bacteria sensitive to all antibiotics. One possible reason
is that the parameters value in Table 1 may not be ideal for modeling a particular
hospital. In order to identify the combination of parameters ideal to mimic the trends
seen in the data, one needs to take the data from a particular hospital and use it to
estimate the parameters. Therefore, the parameters must be identifiable, and, if so,
an inverse problem can be formulated to estimate the parameters. In the next section
we focus on identifiability of parameters in the model.
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Figure 3: Simulation for the new model given by Eq. (1)
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3 IDENTIFIABILITY AND SENSITIVITY ANALYSIS
In the previous section, we discussed that the choice of parameters may need to
be examined further in order for simulations to better represent the data found in
the literature. Therefore, in this section we examine the identifiability of the model,
so that in the future, this model can be adapted to a specific hospital. There are
many approaches in which one can examine identifiability. Eisenberg [13] uses a dif-
ferential algebra approach which involves reducing the system of differential equations
to an input-output equation to determine identifiable parameters. This process was
attempted with our model; however, the resulting input-output equations were quite
messy and therefore hard to use to determine the identifiable parameters.
Another approach for determining a subset of identifiable parameters is given in
the paper by Cintron-Arias et al. [8]. The Fisher Information Matrix (FIM) associated
with the model helps to determine the number of identifiable parameters in the given
subset of parameters. The Fisher Information Matrix is given by
FIM = χTχ (2)
where χ is the sensitivity matrix of the system discussed below. The rank of the
FIM gives the number of identifiable parameters from the given subset. All possible
parameter combinations can be tested until the Fisher Information Matrix has full
rank. Therefore, for identifiability, we need the FIM to have full rank.
Output for our model can be denoted by
z(ti, q0) = (S(ti, q0), R(ti, q0),M(ti, q0))
where ti is a time point and q0 is a given parameter value. If the model is a good
16
model for the spread of resistant bacteria, the output of the model should match data
from a hospital fairly well. But, normally patients aren’t tested for resistant bacteria
while in a hospital unless treatment fails. Therefore, in our model, we assume the only
measurable output from the model would be the number of patients in the hospital
colonized with bacteria of multiple antibiotic resistance which can be obtained from
z(ti, q0) = NM(ti, q0) where N is the population of the hospital and M(ti, q0) is the
proportion of the patients colonized with bacteria of multiple antibiotic resistance.
We needed the sensitivity matrix to calculate the Fisher Information Matrix;
therefore, we describe the sensitivity analysis for the given model and then use this
analysis to aid in identifiability. The sensitivity matrix χ = ∂M
∂qi
is given below, where
q = [mS µS β pT τ γ mR µR cR τR eτ mM cM τM ]
is the vector of parameters in the model and
χ =

∂M(t1)
∂mS
· · · ∂M(t1)
∂τM
∂M(t2)
∂mS
· · · ∂M(t2)
∂τM
...
. . .
...
∂M(tn)
∂mS
· · · ∂M(tn)
∂τM
 . (3)
Traditional sensitivity analysis, as defined by Hamby [14], uses the modified L2 norm∥∥∥∥∂M∂q
∥∥∥∥
2
=
1
max
t0≤t≤tf
(M(t))
[
1
tf − t0
∫ tf
t0
(
∂M
∂q
q
)2
dt
] 1
2
(4)
to determine the relative ranking of the sensitivity of M to the various parameters
where tf = 30(days) is the finishing time and t0 = 0. The result from the sensitivity
analysis is shown in Figure 4. Based on what is shown in this analysis, we can conclude
that the model is most sensitive to the parameters mS, β, τM . When changed, those
parameters result in the most change in M .
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Figure 4: Sensitivity analysis for the model given by Eq (1)
Back to the concept of identifiability, the size of the FIM is 15× 15, but the rank
of the FIM is 11. So it is not full rank and the full set of parameters is not identifiable.
It is possible to choose subsets of parameters, but instead we first analyze the system
and reparameterize it to remove all sums and products which we know cannot be
identified separately. For instance consider the product, eττ in the differential equa-
tion. When eτ is increased and τ is decreased by the same proportion, the product
is the same. We reparameterize the model; the new parameters are given in Table 2.
The schematic for the reparameterized model is given in Figure 5 with the associated
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ordinary differential equation system given by Eq. (5).
dS
dt
= λmS − SµS + βSX − (τ + γ)S − βTRS, (5)
dR
dt
= λmR −RµR + τ˜SS + βT (RS −R2 −RM)− (τR + γ)R + βRXRX,
dM
dt
= λmM −MµM + βMXMX + βT (R2 +RM) + τ˜RR−M(α + γ).
Table 2: New parameter values for identifiability
New Parameter Original Parameter
τ˜S τeτ
τ˜R τReτ
τ˜M τMeτ
βT βPT
βRX β(1− cR)
βMX β(1− cM)
α τM(1− eτ )
19
Figure 5: Schematic for the reparameterized model
Recalculating the Fisher Information Matrix using the reparameterized system
with 16 new parameters, we have a rank of 15. It is still not full rank. The parameter
γ represents the ability of the immune system to kill off the bacteria. It is more likely
to find data on how long it would take for a person’s immune system to fight off
something like antibiotic resistance. After removing γ from the parameter list, FIM
is full rank. Thus the remaining parameters,
q = [mS µS mR µR mM µM β βT βRX βMX τ τR τ˜S τ˜R α ]
are structurally identifiable. We will consider this reparameterized model for the
remainder of this thesis.
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4 PARAMETER ESTIMATION
The forward problem assumes that given a parameter q = q0, the solution of the
model in
dZ
dt
= f(t, Z(t), q0) (6)
can be calculated where Z is the vector of variables Z = [S,R,M,X]. The inverse
problem assumes some observable data from which the parameter q0 can then be
estimated. As mentioned previously, we assume the number of patients colonized
with multiple resistant bacteria, Y = NM , are likely the only population which can
be measured in a hospital setting. Therefore, even though we are still unlikely to be
able to identify every patient with multiple resistance, we are going to assume that
is possible in this thesis to establish the ability to estimate parameters in the best
possible case. We assume the data, yi, is one realization for the statistical model
Yi = M(ti, q0) + εi (7)
where Yi is a random variable , and M(ti, q0) is the solution of Eq. (5) where q0 is as-
sumed to be some true parameter corresponding to the data. It shows the observation
is equal to the model output, which is the solution to the forward problem given the
true parameter q0, plus any measurement error. The terms εi, i = 1, 2, . . . are inde-
pendent and identically distributed random variables satisfying a normal distribution
with mean 0 and variance var(εi) = σ
2
0 <∞ i.e. εi ≈ N(0, σ20).
Given the assumption for the statistical model, we use ordinary least squares for
the parameter estimation in which we estimate parameter qˆ. The cost function is
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shown as follows
qˆ = argmin
q
n∑
i
([yi −M(ti, q)]2) (8)
where yi is the data assumed to be a realization of the model in Eq. (7) and M(ti, q)
is the solution of Eq. (5) for a given parameter q.
We use the package fminsearchcon developed for Matlab in this minimization
problem [15]. This algorithm is adapted from the built-in minimization routine
fminsearch. Both of them are used to find the minimum of a given cost function. We
chose fminsearchcon because it allows one to input parameter constraints. The lower
bound and upper bound are two of the constraints. We let all of the parameters have
lower bound 0. Since some of the parameters mS, µS, mR, µR, mM , µM , τ, τR,
τ˜S, τ˜R, α are proportions, they should less than 1. The incoming patient constraints
are mS > mR > mM . This occurs because most of the patients who are admitted to
the hospital are sensitive to most of the drugs. There are barely any patients resistant
to multiple drugs. The departure rate constraints are µS > µR > µM . Patients who
are sensitive to most of the drugs would be cured quicker than patients who are resis-
tant to drug treatment. The treatment rate constraints are τ > τR > τ˜S > τ˜R. The
treatment rate of patients who are drug sensitive should be quicker than the treatment
rate of patients who are drug resistant. A few patients will develop resistance to a
drug during treatment. The colonization rate constraints are β > βRX > βMX > βT .
When patients contact each other, we assume the uncolonized transfer to colonized
with multiple drug resistance is more difficult than becoming colonized with singleton
drug resistance. The transfer by conjugation is least likely to happen.
In this thesis, we generate simulated data in order to determine the ability to
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estimate parameters. To generate the data, we use Eq. (7) where we use the command
randn in Matlab to generate the term εi with mean 0. Using an initial guess close to
the actual parameters, we obtain the estimates given in Table 3. The absolute and
relative error give an idea of the accuracy of our estimates error, where absolute error
is given by
Absolute error = |q0 − qˆ|,
and relative error can be calculated as
Relative error =
|q0 − qˆ|
|q0| .
The data together with the solution using the estimated parameters is shown in Figure
6. These are estimated parameter values; the confidence intervals will be given in the
next section when we discuss uncertainty analysis.
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Table 3: Estimated Parameter Values and Calculated Error
Parameter True value q0 Estimated value qˆ Absolute error Relative error %
mS 7.0000e-01 6.5302e-01 4.6977e-02 6.7110e+00
µS 2.0833e-01 1.3407e-01 7.4268e-02 3.5649e+01
mR 5.0000e-02 3.5278e-02 1.4722e-02 2.9445e+01
µR 1.6801e-01 9.9447e-02 6.8564e-02 4.0809e+01
mM 5.0000e-03 5.0366e-03 3.6638e-05 7.3275e-01
µM 8.4005e-02 9.9444e-02 1.5439e-02 1.8378e+01
β 1.0000e+00 8.9694e-01 1.0306e-01 1.0306e+01
βT 1.0000e-06 1.1738e-06 1.7376e-07 1.7376e+01
βRX 9.5000e-01 8.7521e-01 7.4795e-02 7.8731e+00
βMX 8.5000e-01 8.7520e-01 2.5200e-02 2.9647e+00
τ 7.8000e-01 7.1135e-01 6.8653e-02 8.8017e+00
τR 5.6000e-01 5.4764e-01 1.2360e-02 2.2071e+00
τ˜S 7.8000e-08 1.7073e-02 1.7073e-02 2.1889e+07
τ˜R 5.6000e-08 1.3684e-03 1.3684e-03 2.4435e+06
α 3.9000e-01 3.7749e-01 1.2508e-02 3.2071e+00
Table 3 shows that the relative error of τ˜S and τ˜R are much larger than the others.
These large relative errors indicate it is not possible to accurately estimate these
parameter values. There is also significant error in the estimated values for µR, mR,
and µS; therefore, although these parameters are structurally identifiable, it may be
difficult to identify these parameters in the presence of noise. We examine the error
in these values further in the next section where we calculate confidence intervals
for these parameters. However, we note that although there is large relative error
in several parameters, Figure 6 shows that the simulation for the model using the
estimated parameters is an extremely good estimate for the model using the exact
parameters.
24
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Figure 6: Solution to Eq (5) with both exact parameters and estimated parameters
given in Table 3 together with simulated data
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5 UNCERTAINTY ANALYSIS
Uncertainty analysis is an important part of a modeling process because there is
variability in the data which effect parameter estimations. Similarly, uncertainty in
the parameter estimations propagate throughout the model. In this section we look
at both uncertainties in the parameter estimations by calculating confidence intervals
as well how this uncertainty propagates through the model. The method used in this
thesis is a bootstrapping method [16, 8]. The following algorithm can be used to
compute the bootstrapping estimate qˆBOOT of q0.
1. First estimate qˆ0 from the entire sample Y Ni using OLS, where qˆ
0 is a first
parameter estimated from Eq. (8).
2. Using this estimate, we define the standardized residuals
r¯i =
√
(
N
N − k0 )(Yi −M(ti; qˆ
0)) for i = 1, . . . , N
where N = 30 is the number of data points and k0 is the number of parameters,
k0 = 15.
3. Create a bootstrapping sample of size N using random sampling with replace-
ment from the data (realizations) {r¯1, . . . , r¯N} to form a bootstrapping sample
{r¯m1 , . . . , r¯mN}. We randomly shuﬄe each individual of the residual set and give
new ordered residual set which is the bootstrapping sample.
4. Create bootstrap sample points
Y mi = M(ti; qˆ
0) + rmi , where i = 1, . . . , 30.
26
In this step, we let the bootstrapping sample replace the measurement error to
get the new sample Y mi ,
5. Obtain a new estimate qˆm from the bootstrapping sample {Y mi } using OLS. We
use same way as step 1 to get new estimate qˆm.
6. Set m = m+ 1 and repeat steps 3-5 until m ≥ 1000.
We let m = 1000 and obtain {qˆm}, m = 1, ..., 1000. The confidence intervals for the
parameter values at the 100(1− α)% level are given by
C = [qˆBOOT − t1−α/2SEk(qˆm), qˆBOOT − t1−α/2SEk(qˆm)] k = 1, . . . , 15, (9)
where qˆBOOT is the mean value of {qˆm}. Let α = 0.05 for 95% confidence intervals.
The critical value t1−α/2 = 1.745884 is computed from the students t distribution
with k0 = 15 degrees of freedom. Standard error is calculated by
SEk(qˆ
m) =
√
Var(qBOOT )kk
where
Var(qBOOT ) =
1
1000− 1
1000∑
m=1
(qˆm − qˆBOOT )T (qˆm − qˆBOOT ).
Confidence intervals are shown in Table 4 providing more information on the extent
of uncertainty involved in estimating q0. The solutions, M(t, qˆm), m = 1, ..., 1000, are
shown in Figure 7.
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Table 4: Confidence Interval for Parameter Estimates
Parameters True value qˆBOOT C
mS 7.0000e-01 6.6946e-01 [ 4.0212e-01 , 9.3679e-01]
µS 2.0833e-01 2.3849e-01 [1.3286e-02 , 4.6369e-01]
mR 5.0000e-02 6.4878e-02 [-7.7942e-02 , 2.0770e-01]
µR 1.6801e-01 1.5298e-01 [7.8344e-03 , 2.9813e-01]
mM 5.0000e-03 4.1250e-03 [2.1650e-03 , 6.0850e-03]
µM 8.4005e-02 7.9443e-02 [2.0312e-02 , 1.3857e-01]
β 1.0000e+00 1.0432e+00 [7.3260e-01 , 1.3537e+00]
βT 1.0000e-06 1.0582e-06 [5.4029e-07 , 1.5761e-06]
βRX 9.5000e-01 9.4735e-01 [7.3691e-01 , 1.1578e+00]
βMX 8.5000e-01 8.6234e-01 [7.6018e-01 , 9.6450e-01]
τ 7.8000e-01 7.8803e-01 [6.3728e-01 , 9.3879e-01]
τR 5.6000e-01 5.9233e-01 [3.5408e-01 , 8.3058e-01]
τ˜S 7.8000e-08 2.1096e-02 [-8.4058e-02 , 1.2625e-01]
τ˜R 5.6000e-08 1.7241e-03 [-3.5549e-03 , 7.0030e-03]
α 3.9000e-01 3.8284e-01 [2.9463e-01 , 4.7106e-01]
The left confidence interval of mR, τ˜S, and τ˜R are negative. As defined, these
parameters should not be negative. Recall that these parameter values are also the
ones which gave the largest initial relative error (see Table 3). This is more indication
that we cannot accurately estimate these parameters. The mean estimated parameter
value for all other parameters had less than 18% relative error with all but two
parameter values resulting in less than 10% relative error.
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Figure 7: Variation in the solution M(t, qˆm) in Eq. (5) given the variability in pa-
rameter values seen in Table 4
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6 EQUILIBRIUM AND STABILITY ANALYSIS
In this section, we analyze the potential of a stable resistance-free equilibrium.
The disease-free equilibrium is not a realistic possibility, since patients will continu-
ously enter the hospital colonized with bacteria; therefore, we consider a resistant-free
equilibrium (RFE) given by ER = (S,R,M,X) = (S
∗, 0, 0, X∗). As discussed in Sec-
tion 2, S +R+M +X = 1; therefore, X = 1− (S +R+M) and thus X∗ = 1− S∗.
S∗ can be calculated by the equation S∗ = dS
dt
|ER = 0, where dSdt is given in Eq. (5).
This gives
S∗ =
β − µS − τ − γ ±
√
(β − µS − τ − γ)2 + 4βλmS
2β
.
We first reorder the system with the resistant variables as given by
dR
dt
= λmR −RµR + τ˜SS + βT (RS −R2 −RM)− (τR + γ)R +
βRXR(1− S −R−M),
dM
dt
= λmM −MµM + βMXM(1− S −R−M) + βT (R2 +RM) +
τ˜RR−M(α + γ),
dS
dt
= λmS − SµS + βS(1− S −R−M)− (τ + γ)S − βTRS.
The stability of the RFE can be computed by using the next generation approach
[17]. We then linearize the reordered system about the RFE. The Jacobian Matrix
evaluated at the RFE is given by
J =
 J11 0 τ˜Sτ˜R J22 0
S∗(−β − βT ) −βS∗ J33

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where
J11 = −(µR + τR + γ) + βTS∗ + βRX(1− S∗)
J22 = −(µM + α + γ) + βMX
J33 = −(µS + τ + γ) + β(1− 2S∗)
The terms in the Jacobian matrix can be separated as new colonizations with
resistant bacteria and all other transitions. The new colonizations are given by
F =
[
F11 0
0 F22
]
where
F11 = βTS
∗ + βRX(1− S∗)
F22 = βMX
and all the other transitions are given by
V =
[
µR + τR + γ 0
−τ˜R µM + α + γ
]
.
V is a non-singular matrix. The matrix product FV −1 is called the next generation
matrix where V −1 is given as:
V −1 =

1
µR + τR + γ
0
τ˜R
(µM + α + γ)(µR + τR + γ)
1
µM + α + γ
 .
The terms Vjk represent the average length of time that a patient stays in compart-
ment j. Then the spectral radius ρ of the matrix FV −1 is defined as follows:
Rs = ρ(FV
−1) = max
{
βTS
∗ + βRX(1− S∗)
µR + τR + γ
,
βMX
µM + α + γ
}
. (10)
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Based on theory developed by Hadeler [17] and using the approach from Snyder [26]
on our spectral radius, Rs, we have the following theorem concerning the model in
Eq. (5).
Theorem 6.1 The resistant-free equilibrium for the model in Eq. (5), RFE =
(S∗, 0, 0, X∗), is locally asymptotically stable if and only if Rs given in Eq. (10)
satisfies Rs < 1.
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7 CONCLUTIONS AND FUTURE WORK
In this thesis, a new model was built by modifying a previous model given in the
paper by Joyner et al. [1]. We then considered the reparameterization of the model
to enable identifiability and then considered parameter estimation. The result of the
simulation of our new model shows that it follows the trend seen in the data more than
the previous model. The parameter estimation resulted in close estimates to the true
parameters. The future work should focus on looking for real data. We need a real
data record from the hospital to support that our model captures the relationships
in an actual hospital. Future work may also include examining if all the important
relationships are considered in our model. Another potential idea for future work
could be using the model to test strategies for reducing antibiotic resistance in the
hospital.
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